"Walmart Teams with Eli Lilly to Offer Weight-Loss Drug Directly to Patients"

Walmart is partnering with Eli Lilly and Company to provide access to the weight-loss drug Zepbound at its pharmacies, a move that could transform obesity treatment for many patients.

• Starting next month, patients with a valid prescription can obtain the weight-loss drug Zepbound directly from Walmart pharmacies across the United States.
• This collaboration between Walmart and Eli Lilly and Company aims to make effective obesity treatments more accessible to a broader range of patients nationwide.
• The new program comes as obesity rates continue to rise, highlighting the increasing demand for effective weight loss solutions in the American healthcare landscape.